Riskpilot← Back to searchSign inGet full accessCELLCURA ASA
ASAActiveOrg 980040461Uniongata 18, 3732 SkienForskning og utviklingsarbeid innen bioteknologi · NACE 72110Est. 19980 employeeswww.cellcura.com
Revenue 2015
NOK 898
EBITDA margin
-20262259.0%
Equity ratio
-182.8%
Financial strength
Net profit 2015
NOK -202,1M
0 employees
| Revenue | NOK 898 | — |
| EBITDA | NOK -182M | — |
| Net profit | NOK -202,1M | — |
| Total assets | NOK 12,6M | — |
| Equity | NOK -23M | — |
| Employees | 0 | — |
Legal name
CELLCURA ASA
Org number
980040461
Legal form
Allmennaksjeselskap
NACE code
72110 · Forskning og utviklingsarbeid innen bioteknologi
Founded
19. juni 1998
Share capital
NOK 1 080 410 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2015-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikle og tilby tjenester og produkter innenfor bioteknologi og helse.
Address
Uniongata 18, 3732 Skien
Website
www.cellcura.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|
| Revenue | 341 | 0 | 0 | 0 | 1 |
| Staff expenses | −3 747 | −0 | −0 | −0 | −135 |
| EBITDA | −21 104 | 0 | 0 | 0 | −181 955 |
| Depreciation & amort. | −5 272 | −0 | −0 | −0 | −4 190 |
| EBIT | −26 375 | 0 | 0 | 0 | −186 145 |
| Net financials | −99 | 0 | 0 | 0 | −15 958 |
| Profit before tax | −26 475 | 0 | 0 | 0 | −202 103 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −26 475 | 0 | 0 | 0 | −202 103 |
| Item | 2011 | 2012 | 2013 | 2014 | 2015 |
|---|---|---|---|---|---|
| Total assets | 53 345 | — | — | — | 12 595 |
| Equity | 35 045 | — | — | — | −23 022 |
| Long-term debt | 12 103 | 0 | 0 | 0 | 15 200 |
| Short-term debt | 5 947 | 0 | 0 | 0 | 20 417 |
| Total debt | 18 050 | 0 | 0 | 0 | 35 617 |
EBITDA margin
-20262259.0%
This company
15.8%
Market median
-128242246% vs market
20112015
Equity ratio
-182.8%
This company
38.2%
Market median
-579% vs market
20112015
Return on equity
-20210312200.0%
This company
18.4%
Market median
-109838653361% vs market
20112015
Net profit margin
-22505915.6%
This company
8.1%
Market median
-277850910% vs market
20112015
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20112015
Debt / equity
1.55×
This company
0.62×
Market median
-150% vs market
20112015
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PB Chief Executive Officer | Chief Executive Officer | 2017 – 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2016 | |
| Chairman | 2016 | |
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CELLCURA ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål Bråthen | Chief Executive Officer | 0 companies |
| Fredrik Grouff Kilde | Board of Directors | 0 companies |
| Dag Øivind Dvergsten | Chairman | 0 companies |
| Kristin Grouff Dvergsten | Board of Directors | 0 companies |